Pfizer Inc. buy Guggenheim
Start price
23.02.24
/
50%
€25.55
Target price
23.02.25
€33.22
Performance (%)
-1.84%
End price
24.02.25
€25.08
Summary
This prediction ended on 24.02.25 with a price of €25.08. With a performance of -1.84%, the BUY prediction for Pfizer Inc. by Guggenheim closed slightly in the red. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €1.58 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | 3.639% | 3.639% | -2.005% |
| iShares Core DAX® | -3,17 % | 1,23 % | 2,54 % |
| iShares Nasdaq 100 | -1,01 % | 0,38 % | 32,25 % |
| iShares Nikkei 225® | -3,60 % | 1,00 % | 59,53 % |
| iShares S&P 500 | 0,21 % | 2,92 % | 24,52 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten